Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy
- Status
- RECRUITING
- Phase
- N/A
Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
AMT-151 in Patients With Selected Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
- Status
- COMPLETED
- Phase
- N/A
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PHL Treatment in Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1